Method of determining a site of inflammation utilizing ELAM-1 ligands
US5211937A · kind A · utility
75Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 1991 |
| Grant date | May 18, 1993 |
| Priority date | — |
| Expiry date | Apr 11, 2011 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ligands in the form of N-acetyllactosamines which bind to endothelial leukocyte adhesion molecule-1 (ELAM-1) are disclosed. The ligand compounds can be formulated into pharmaceutical compositions and/or assay compositions used to alleviate inflammation and assay for the presence of (qualitative) and amount of (quantitative) ELAM-1 and thereby determine the presence, location and degree of inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.